Clindamycin and rifampicin addition to adalimumab benefit patients with hidradenitis suppurativa with draining tunnels Medha Baranwal14 Jan 2024 7:00 PM ISTNetherlands: A recent study published in the Journal of the European Academy of Dermatology and Venereology showed improved clinical effectiveness of...
Heat shock protein 90 inhibition effective and safe option against Hidradenitis Suppurativa Jacinthlyn Sylvia9 Jan 2024 10:30 AM ISTIn a recent clinical trial discovered promising outcomes of heat shock protein 90 inhibition by RGRN-305 for individuals suffering from moderate to...
HSP90 inhibition novel mechanism for treating hidradenitis suppurativa: JAMA Medha Baranwal5 Jan 2024 10:15 AM ISTDenmark: Findings from a parallel-design, double-blind trial published in JAMA Dermatology have offered a potential new therapeutic option for...
Povorcitinib Shows Positive Outcomes For Hidradenitis Suppurativa in phase 2 trial Jacinthlyn Sylvia7 Dec 2023 8:30 PM ISTA recent study published in the Journal of the American Academy of Dermatology found the potential benefits of povorcitinib, a selective oral Janus...
Clindamycin-benzoyl peroxide gel may reduce antibiotic resistance and improve clinical efficacy in hidradenitis suppurativa Aditi22 Nov 2023 9:45 AM ISTAccording to a recent study published in Dermatology, clindamycin-benzoyl peroxide gel showed favourable clinical efficacy results, similar to...
Novartis wins USFDA nod for Cosentyx to treat hidradenitis suppurativa in adults Ruchika Sharma1 Nov 2023 2:00 PM ISTBasel: Novartis has announced that the US Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) to treat moderate to severe...
FDA approves first new biologic treatment option for hidradenitis suppurativa patients Dr. Kamal Kant Kohli1 Nov 2023 10:45 AM ISTThe US Food and Drug Administration (FDA) has approved secukinumab as first new biologic treatment option for moderate to severe hidradenitis...
Clascoterone cream effective for patients with mild to moderate Hidradenitis suppurativa Medha Baranwal26 Sept 2023 9:45 AM ISTUSA: A recent study published in the Journal of the American Academy of Dermatology has shown clascoterone to be beneficial for treating patients with...
Novartis Cosentyx gets European Commission nod for use in adults with hidradenitis suppurativa Ruchika Sharma1 Jun 2023 11:00 AM ISTA regulatory decision from the US Food and Drug Administration is expected later this year.
Adalimumab improves hidradenitis suppurativa outcomes among obese patients Jacinthlyn Sylvia23 May 2023 7:15 PM ISTFor overweight and obese individuals with moderate to severe hidradenitis suppurativa (HS), an increased adalimumab dosage may be linked to better...
Metformin use may prevent immune-mediated skin diseases in type 2 diabetes patients Medha Baranwal5 May 2023 11:00 AM ISTTaiwan: Metformin use in patients with type 2 diabetes is associated with a remarkably lower risk of immune-mediated skin diseases, a recent study has...
Novartis gets positive CHMP opinion for Cosentyx in adults with hidradenitis suppurativa Ruchika Sharma30 April 2023 10:00 AM ISTCosentyx is the first and only fully human biologic that directly inhibits interleukin-17A, an important cytokine involved in the inflammation of...
